EVOTEC SE (EVT.DE) Fundamental Analysis & Valuation

FRA:EVT • DE0005664809

Current stock price

4.53 EUR
+0 (+0.09%)
Last:

This EVT.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EVT.DE Profitability Analysis

1.1 Basic Checks

  • EVT had negative earnings in the past year.
  • EVT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: EVT reported negative net income in multiple years.
  • Each year in the past 5 years EVT had a positive operating cash flow.
EVT.DE Yearly Net Income VS EBIT VS OCF VS FCFEVT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • EVT has a worse Return On Assets (-8.97%) than 80.95% of its industry peers.
  • EVT has a worse Return On Equity (-19.87%) than 76.19% of its industry peers.
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROIC N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
EVT.DE Yearly ROA, ROE, ROICEVT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • EVT has a Gross Margin of 10.82%. This is amonst the worse of the industry: EVT underperforms 85.71% of its industry peers.
  • EVT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EVT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
EVT.DE Yearly Profit, Operating, Gross MarginsEVT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EVT.DE Health Analysis

2.1 Basic Checks

  • EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EVT has more shares outstanding
  • Compared to 5 years ago, EVT has more shares outstanding
  • EVT has a better debt/assets ratio than last year.
EVT.DE Yearly Shares OutstandingEVT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EVT.DE Yearly Total Debt VS Total AssetsEVT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.40, we must say that EVT is in the distress zone and has some risk of bankruptcy.
  • EVT has a worse Altman-Z score (0.40) than 85.71% of its industry peers.
  • A Debt/Equity ratio of 0.48 indicates that EVT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.48, EVT is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC6.93%
EVT.DE Yearly LT Debt VS Equity VS FCFEVT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • EVT has a Current Ratio of 2.12. This indicates that EVT is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of EVT (2.12) is better than 85.71% of its industry peers.
  • A Quick Ratio of 2.03 indicates that EVT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.03, EVT belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 2.03
EVT.DE Yearly Current Assets VS Current LiabilitesEVT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EVT.DE Growth Analysis

3.1 Past

  • EVT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.17%.
  • The Revenue has decreased by -2.67% in the past year.
  • The Revenue has been growing by 12.29% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, EVT will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y62.82%
EPS Next 2Y35.95%
EPS Next 3Y27.94%
EPS Next 5Y18.42%
Revenue Next Year-1.62%
Revenue Next 2Y-0.7%
Revenue Next 3Y3.15%
Revenue Next 5Y5.29%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EVT.DE Yearly Revenue VS EstimatesEVT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
EVT.DE Yearly EPS VS EstimatesEVT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. EVT.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • EVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year EVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVT.DE Price Earnings VS Forward Price EarningsEVT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EVT is valued a bit more expensive than 76.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 529.3
EVT.DE Per share dataEVT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EVT's earnings are expected to grow with 27.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.95%
EPS Next 3Y27.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EVT.DE Dividend Analysis

5.1 Amount

  • No dividends for EVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EVT.DE Fundamentals: All Metrics, Ratios and Statistics

EVOTEC SE

FRA:EVT (4/10/2026, 7:00:00 PM)

4.53

+0 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05
Earnings (Next)N/A
Inst Owners61.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap805.80M
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts76.92
Price Target7.28 (60.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.59%
Min EPS beat(2)-21.86%
Max EPS beat(2)-3.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.12%
Revenue beat(16)7
Avg Revenue beat(16)2.95%
PT rev (1m)-15.63%
PT rev (3m)-15.63%
EPS NQ rev (1m)10.71%
EPS NQ rev (3m)63.16%
EPS NY rev (1m)0%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)1.68%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)1.29%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.07
P/FCF N/A
P/OCF 571.49
P/B 1.01
P/tB 1.61
EV/EBITDA 529.3
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)0.01
OCFY0.17%
SpS4.25
BVpS4.5
TBVpS2.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -19.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.82%
FCFM N/A
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA 209.82
Cap/Depr 90.72%
Cap/Sales 12.19%
Interest Coverage N/A
Cash Conversion 76.3%
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 2.03
Altman-Z 0.4
F-Score4
WACC6.93%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y62.82%
EPS Next 2Y35.95%
EPS Next 3Y27.94%
EPS Next 5Y18.42%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-1.62%
Revenue Next 2Y-0.7%
Revenue Next 3Y3.15%
Revenue Next 5Y5.29%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year131.95%
EBIT Next 3Y47.8%
EBIT Next 5Y33.1%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%

EVOTEC SE / EVT.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EVOTEC SE?

ChartMill assigns a fundamental rating of 3 / 10 to EVT.DE.


What is the valuation status for EVT stock?

ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (EVT.DE). This can be considered as Overvalued.


Can you provide the profitability details for EVOTEC SE?

EVOTEC SE (EVT.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for EVT stock?

The financial health rating of EVOTEC SE (EVT.DE) is 5 / 10.